Back to results
US 8,912,161 B2Granted
MicroRNA compounds and methods for modulating miR-21 activity
AssigneeRegulus Therapeutics Inc.
InventorBalkrishen Bhat
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer.
Claims10
A compound comprising a modified oligonucleotide having the structure:
- (SEQ ID NO:
- 3)
- AECSATCSAGTCSTGAUSAAGCSTAE,
- wherein nucleosides not followed by a subscript are β-D-deoxyribonucleosides;
- nucleosides followed by a subscript “E” are 2′-methoxyethyl (2′-MOE) nucleosides;
- and nucleosides followed by a subscript “S” are S-constrained ethyl (S-cEt) nucleosides.
3 more elements
A compound comprising a modified oligonucleotide having the structure:
- (SEQ ID NO:
- 3)
- AECSATCSAGTCSTGAUSAAGCSTAE,
- wherein nucleosides not followed by a subscript are β-D-deoxyribonucleosides;
- nucleosides followed by a subscript “E” are 2′-methoxyethyl (2′-MOE)nucleosides;
- and nucleosides followed by a subscript “S” are S-constrained ethyl (S-cEt) nucleosides;
- and wherein each internucleoside linkage of the modified oligonucleotide is a phosphorothioate linkage.
4 more elements
Dependencies are inferred from the claim text.